Are we nearing the COVID-19 peak? Share markets have responded positively to stimulus efforts and signs that global efforts to slow the spread of the virus are working.
US markets rose Wednesday after Trump said the world’s #1 economy might be flattening the COVID-19 infection ‘curve’.
Democrats in US Congress also agreed to back the Trump administration’s request for an additional $US250bn ($400bn) in small business support.
Major US health insurers went for a run after democratic candidate Bernie Sanders — who was campaigning on a Medicare-like ‘health care for all’ platform — dropped out of the presidential race.
Here’s more good news; global oil prices rose on Wednesday after Russia said it was ready to cut crude production by 1.6 million barrels a day at the OPEC meeting on Thursday.
And in Australia, where the rate of new COVID-19 cases continues to fall, federal parliament has approved the government’s $130bn JobKeeper legislation.
This will ostensibly provide a $1,500 per fortnight wage subsidy for about 6 million workers.
Over 730,000 businesses have already registered with the Australian Taxation Office for access to the scheme, the single largest chunk of government spending in Aussie history.
“The JobKeeper payment is critical to the survival of small businesses that have been impacted by the COVID-19 crisis,” Australian Small Business and Family Enterprise Ombudsman Kate Carnell says.
“We know that there’s never been a tougher time to be in business, but the JobKeeper package provides the practical financial support and the hope small businesses need as we wait for this health crisis to pass.”
The local bourse has recovered slightly (at least temporarily) since that precipitous drop in late March.
The performance of the ASX 200 (orange) and All Ords (white) year-to-date.
The ASX 200 (+1.49 per cent today) and Small Ords Index (+1.78 per cent today) are now up 16.2 per cent and 21.7 per cent respectively since March 23.
WINNERS
Here are the best performing ASX small cap stocks at 12pm Thursday April 9:
Swipe or scroll to reveal the full table. Click headings to sort.
“It’s a great time to do a deal like this,” he said, as companies across the ASX struggle for money and are looking for ways to save cash.
Aussie pharmaceutical manufacturer IDT (ASX:IDT) has been asked to assist with “certain COVID‐ 19 response activities” by the Australian government.
“To this end IDT’s GMP pharmaceutical manufacturing facilities and laboratory remain fully operational and business operations continue without disruption,” the company told investors.
“The company continues to closely manage costs and our revenues are presently tracking in line with budget as we push towards profitability.”
Ardiden picked up some extra ground around its Pickle Lake gold project in Canada, which is now “comparable in size to that of the 30-million-ounce Red Lake producing district next door”, says managing director Rob Longley. Whether Pickle Lake holds 30moz remains to be seen.
Get the latest Stockhead news delivered free to your inbox
For investors, getting access to the right information is critical.
Stockhead’s daily newsletters make things simple: Markets coverage, company profiles and industry insights from Australia’s best business journalists – all collated and delivered straight to your inbox every day.
Markets coverage, company profiles and industry insights from Australia’s best business journalists – all collated and delivered straight to your inbox every day.
It’s free. Unsubscribe anytime.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.
I want the news:
"*" indicates required fields
Hear it first
Get the latest Stockhead news delivered free to your inbox.
Thanks! You’re subscribed, Stockhead news is coming your way soon.